EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 174 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $309,000 | -10.4% | 5,790 | 0.0% | 0.11% | -15.3% |
| Q3 2017 | $345,000 | -6.2% | 5,790 | +24.1% | 0.13% | -10.9% |
| Q2 2017 | $368,000 | +4.0% | 4,665 | +9.4% | 0.15% | -2.0% |
| Q1 2017 | $354,000 | +4.1% | 4,265 | -0.6% | 0.15% | -6.8% |
| Q4 2016 | $340,000 | -3.1% | 4,290 | -14.5% | 0.16% | 0.0% |
| Q3 2016 | $351,000 | -82.3% | 5,015 | -77.6% | 0.16% | -82.2% |
| Q4 2015 | $1,984,000 | +19.8% | 22,375 | 0.0% | 0.91% | +14.7% |
| Q3 2015 | $1,656,000 | +46.9% | 22,375 | +60.5% | 0.79% | +75.2% |
| Q2 2015 | $1,127,000 | – | 13,940 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |